Chaitan Khosla Ph.D., Director at Protagonist Therapeutics, Inc (PTGX), sold 2,499 shares at $17.19 ($43K) on 2020-08-11, disclosed to the SEC on 2020-08-12.
Scheduled sale ($43k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| KOSN | SELL | 2006-03-16 | $38K | — | Filing → |
| KOSN | SELL | 2006-02-10 | $20K | — | Filing → |